Eastern Cooperative Oncology Group E1A00: phase III randomized study of dexamethasone with or without thalidomide in patients with newly diagnosed multiple myeloma.
Greipp
Philip R
PR
Mayo Clinic, USA.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002985:Clinical Protocols; D003907:Dexamethasone / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D018579:Patient Selection; D013792:Thalidomide / Q000627:therapeutic use*
D013792:Thalidomide; D003907:Dexamethasone